Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Share-based Compensation (2020 - 2025)

NeuroPace has reported Share-based Compensation over the past 6 years, most recently at $2.6 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $2.6 million for Q4 2025, changed 0.15% from a year ago — trailing twelve months through Dec 2025 was $11.1 million (up 7.85% YoY), and the annual figure for FY2025 was $11.1 million, up 7.85%.
  • Share-based Compensation for Q4 2025 was $2.6 million at NeuroPace, down from $2.6 million in the prior quarter.
  • Over the last five years, Share-based Compensation for NPCE hit a ceiling of $3.2 million in Q2 2025 and a floor of $202000.0 in Q1 2021.
  • Median Share-based Compensation over the past 5 years was $2.5 million (2023), compared with a mean of $2.2 million.
  • Biggest five-year swings in Share-based Compensation: plummeted 32.89% in 2021 and later soared 636.63% in 2022.
  • NeuroPace's Share-based Compensation stood at $1.9 million in 2021, then increased by 10.66% to $2.1 million in 2022, then rose by 13.54% to $2.4 million in 2023, then grew by 10.44% to $2.6 million in 2024, then rose by 0.15% to $2.6 million in 2025.
  • The last three reported values for Share-based Compensation were $2.6 million (Q4 2025), $2.6 million (Q3 2025), and $3.2 million (Q2 2025) per Business Quant data.